Detail Information of Exogenous Modulation
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0375 Transporter Info | ||||
Gene Name | SLC48A1 | ||||
Transporter Name | Heme transporter HRG1 | ||||
Gene ID | |||||
UniProt ID | |||||
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM) | |||||
---|---|---|---|---|---|
Chemical Compound |
|||||
DT Modulation1 |
Cisplatin co-treated with jinfukang results in increased expression of SLC48A1 mRNA | [7] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
SLC48A1 protein results in decreased susceptibility to Arsenic Trioxide | [30] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
Valproic Acid affects the expression of SLC48A1 mRNA | [6] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
1-Methyl-3-isobutylxanthine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A results in increased expression of SLC48A1 mRNA | [27] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
abrine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
abrine results in decreased expression of SLC48A1 mRNA | [28] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
beta-Naphthoflavone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
beta-Naphthoflavone results in increased expression of SLC48A1 mRNA | [22] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
bisphenol A |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bisphenol A results in increased expression of SLC48A1 mRNA | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A results in increased expression of SLC48A1 mRNA | [27] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
bufotalin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bufotalin results in decreased expression of SLC48A1 mRNA | [31] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Cadmium Chloride |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cadmium Chloride results in increased abundance of Cadmium which results in decreased expression of SLC48A1 mRNA | [32] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Cadmium Chloride results in increased expression of SLC48A1 mRNA | [33] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
clothianidin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
clothianidin results in increased expression of SLC48A1 mRNA | [19] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Dexamethasone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A results in increased expression of SLC48A1 mRNA | [27] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
dicrotophos |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
dicrotophos results in increased expression of SLC48A1 mRNA | [18] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Estradiol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Estradiol co-treated with TGFB1 protein results in decreased expression of SLC48A1 mRNA | [34] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Indomethacin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A results in increased expression of SLC48A1 mRNA | [27] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
lead acetate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
lead acetate results in increased expression of SLC48A1 mRNA | [36] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
quinocetone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
quinocetone results in decreased expression of SLC48A1 mRNA | [37] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
S-(1,2-dichlorovinyl)cysteine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides which results in increased expression of SLC48A1 mRNA | [38] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
sodium arsenite |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
sodium arsenite results in increased abundance of Arsenic which results in increased expression of SLC48A1 mRNA | [29] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
sodium arsenite results in increased expression of SLC48A1 mRNA | [39] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
sulforaphane |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
sulforaphane results in increased expression of SLC48A1 mRNA | [20] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
triphenyl phosphate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
triphenyl phosphate affects the expression of SLC48A1 mRNA | [40] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
zinc chloride |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
zinc chloride results in increased expression of SLC48A1 mRNA | [2] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Approved Drug |
|||||
Fluorouracil |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Fluorouracil affects the expression of SLC48A1 | [1] | |||
Copper Sulfate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Copper Sulfate increases the expression of SLC48A1 | [3] | |||
Cyclosporine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cyclosporine increases the expression of SLC48A1 | [4] | |||
Tretinoin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Tretinoin increases the expression of SLC48A1 | [5] | |||
Carbamazepine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Carbamazepine affects the expression of SLC48A1 | [6] | |||
Cisplatin |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cisplatin increases the expression of SLC48A1 | [7] | |||
Urethane |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Urethane inhibits the expression of SLC48A1 | [8] | |||
Sunitinib |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Sunitinib increases the expression of SLC48A1 | [9] | |||
Temozolomide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Temozolomide increases the expression of SLC48A1 | [10] | |||
Arsenic Trioxide |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Arsenic Trioxide increases the expression of SLC48A1 | [11] | |||
Acetaminophen |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Acetaminophen increases the expression of SLC48A1 | [12] | |||
Valproic Acid |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Valproic Acid increases the expression of SLC48A1 | [13] | |||
Drug Marketed but not Approved by US FDA |
|||||
Zinc chloride |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Zinc chloride increases the expression of SLC48A1 | [2] | |||
Drug in Phase 3 Trial |
|||||
Curcumin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Curcumin increases the expression of SLC48A1 | [14] | |||
Sulforafan |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Sulforafan increases the expression of SLC48A1 | [20] | |||
Drug in Phase 2 Trial |
|||||
Bisphenol A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Bisphenol A increases the expression of SLC48A1 | [16] | |||
Drug in Phase 1 Trial |
|||||
Sodium arsenite |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Sodium arsenite increases the expression of SLC48A1 | [26] | |||
Investigative Drug |
|||||
Beta-naphthoflavone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Beta-naphthoflavone increases the expression of SLC48A1 | [22] | |||
Natural Product |
|||||
Tobacco Smoke Pollution |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Tobacco Smoke Pollution increases the expression of SLC48A1 | [23] | |||
Traditional Medicine |
|||||
Jinfukang |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Jinfukang increases the expression of SLC48A1 | [7] | |||
Environmental toxicant |
|||||
Zinc |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Zinc increases the expression of SLC48A1 | [2] | |||
DT Modulation1 |
Lead affects the expression of SLC48A1 mRNA | [35] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Mycotoxins |
|||||
Aflatoxin B1 |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Aflatoxin B1 increases the expression of SLC48A1 | [24] | |||
DT Modulation2 |
Aflatoxin B1 affects the expression of SLC48A1 protein | [4] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Acute Toxic Substance |
|||||
Acrylamide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Acrylamide inhibits the expression of SLC48A1 | [21] | |||
Carcinogen |
|||||
Benzo(a)pyrene |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Benzo(a)pyrene increases the expression of SLC48A1 | [25] | |||
Arsenic |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
sodium arsenite results in increased abundance of Arsenic which results in increased expression of SLC48A1 mRNA | [29] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Cadmium |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cadmium Chloride results in increased abundance of Cadmium which results in decreased expression of SLC48A1 mRNA | [32] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Pesticide/Insecticide |
|||||
Dicrotophos |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Dicrotophos increases the expression of SLC48A1 | [18] | |||
Clothianidin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Clothianidin increases the expression of SLC48A1 | [19] | |||
Health and Environmental Toxicant |
|||||
Lead |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Lead inhibits the expression of SLC48A1 | [15] | |||
tris(1,3-dichloro-2-propyl)phosphate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of SLC48A1 | [17] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.